The experiment was divided into a normal control group, a radiotherapy model group, and a radiotherapy+IGF-1 LR3 treatment group (1mg/kg, orally taken from the first day after radiotherapy, once a day, for 7 consecutive days)
Recommended Dosage Typical dose : 515 mg per week, split into 23 injections Injection frequency : 23x weekly (e.g., Monday, Wednesday, Friday) Cycle length : 24 weeks on, followed by 24 weeks off Injection method : Subcutaneous (abdomen, thigh, or flank area) Beginners often start with 5 mg/week and titrate up based on response and tolerance
Research on the abdominal fluid (which surrounds the ovaries) of both fertile and infertile women demonstrated that higher levels of reactive oxidative species (ROS) were present in the fluid taken from patients with unexplained infertility
NAMPT-induced genes associated with effectors of stemness pathways, which increased tumorigenicity and regulated the CSC phenotype